VAERS 2648189
UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge UJ496AAA
- Staat
- CA
- Alter
- 0,8
- Geschlecht
- M
- Eingang
- 22.06.2023
- Impfdatum
- 29.09.2022
- Beginn
- 29.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / RL
Symptomtext
fever; patient received a dose of pentacel that expired; Initial information received on 30-Sep-2022 regarding an unsolicited valid non-serious case received from a physician. This case involves a 10 months old male patient who was having fever and patient received a dose of pentacel (DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE [PENTACEL (VERO)] that expired. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 29-Sep-2022, the patient received 0.5 ml third dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE (formulation, strength: unknown) lot number: UJ496AAA, expiration date: 09-Jul-2022, via intramuscular route in right vastus lateralis as Immunization On 29-Sep-2022 the patient received a dose of pentacel that expired (expired product administered) (same day) following the administration of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE. On an unknown date the patient had fever (pyrexia) (unknown latency) following the administration of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE. Action taken was not applicable. It was not reported if the patient received a corrective treatment for the events (fever, patient received a dose of pentacel that expired). At time of reporting, the outcome was Unknown for all. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. Additional information received on 30-Sep-2022 from other health care professional: therapy details, therapy start date, batch number and expiry date updated for the suspect, event onset date updated for expired product administered, text amended accordingly
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -